Syria vs Tuvalu: Average non-HDL cholesterol levels

Syria
3.4
in 2018
Tuvalu
3.4
in 2018
Syria rank
75th
Tuvalu rank
75th

Average non-HDL cholesterol levels over time

  • Syria
  • Tuvalu
01234198019992018

How they compare

Syria currently reports 3.4 against 3.4 in Tuvalu, a difference of 0.

Across all 39 years both countries report, Tuvalu has been ahead every year.

Syria ranks 75th and Tuvalu ranks 75th of 191 countries.

Tuvalu has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade Syria Tuvalu Difference Ahead
1980s 3.44 3.57 0.13 Tuvalu
1990s 3.61 3.78 0.17 Tuvalu
2000s 3.63 3.71 0.08 Tuvalu
2010s 3.48 3.53 0.0556 Tuvalu

Averages of every year both report within each decade.

Frequently asked questions

Which has higher average non-hdl cholesterol levels, Syria or Tuvalu?
Syria, at 3.4 against 3.4 in Tuvalu as of 2018.
What is the difference in average non-hdl cholesterol levels between Syria and Tuvalu?
0, with Syria ahead.
How many years of comparable data are there for Syria and Tuvalu?
39 years are reported by both, from 1980 to 2018.
How do Syria and Tuvalu rank globally for average non-hdl cholesterol levels?
Syria ranks 75th and Tuvalu ranks 75th of 191 countries.
Where does this data come from?
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.